2m 2m 2m 2m 2m 2m 2m
iRadimed (IRMD)
NASDAQ
$90.95+$1.08 (+1.21%)
Price as of Jun 03, 2026 4:55 PM EDT- $1.2BMarket Cap
- 52.39%1-Year Change
- Medical DevicesIndustry
iRadimed (IRMD)
$90.95+$1.08 (+1.21%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 83.8M +14.43% | 73.2M +11.71% | 65.6M +23.00% | 53.3M +27.48% | |
Cost of Revenue | 19.5M +15.38% | 16.9M +9.66% | 15.4M +28.15% | 12.0M +23.10% | |
Gross Profit | 64.3M +14.15% | 56.3M +12.34% | 50.2M +21.50% | 41.3M +28.81% | |
Sales and Marketing Expense | 17.4M +11.55% | 15.6M +28.61% | 12.1M -4.24% | 12.7M +20.12% | |
Research and Development Expense | -3.0M +5.06% | -2.8M -0.95% | -2.9M +25.49% | -2.3M +19.58% | |
Depreciation and Amortization Expense | 1.2M +42.60% | 817,656 +6.86% | 765,180 +14.09% | 670,673 -52.33% | |
Total Operating Expenses | 38.2M +11.03% | 34.4M +14.15% | 30.1M +17.42% | 25.7M +15.39% | |
Operating Profit | 26.1M +19.04% | 22.0M +9.63% | 20.0M +28.21% | 15.6M +59.18% | |
Interest Income | 2.0M -8.40% | 2.2M +17.65% | 1.9M +220.38% | 581,852 +1,571.70% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 2.0M -8.40% | 2.2M +17.65% | 1.9M +220.38% | 581,852 +1,571.70% | |
Total Nonoperating Income and Expense | 2.2M -4.19% | 2.3M +35.70% | 1.7M +207.86% | 553,104 +2,872.88% | |
Income before Taxes | 28.4M +16.83% | 24.3M +11.67% | 21.7M +34.35% | 16.2M +64.50% | |
Income Taxes | 5.9M +16.65% | 5.0M +10.91% | 4.5M +35.59% | 3.4M +556.26% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 22.5M +16.88% | 19.2M +11.87% | 17.2M +34.02% | 12.8M +37.56% | |
Net Income from Continuing Operations Applicable to Common | 28.4M +16.83% | 24.3M +11.67% | 21.7M +34.35% | 16.2M +64.50% | |
Basic EPS and Net Income | 1.77 +16.45% | 1.52 +11.76% | 1.36 +33.33% | 1.02 +34.21% | |
Diluted EPS and Net Income | 1.75 +16.67% | 1.50 +11.11% | 1.35 +32.35% | 1.02 +37.84% | |
Basic Weighted Average Shares | 12.7M +0.41% | 12.7M +0.53% | 12.6M +0.32% | 12.6M +1.76% | |
Diluted Weighted Average Shares | 12.9M +0.55% | 12.8M +0.48% | 12.7M +0.69% | 12.6M +0.36% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 51.2M -2.06% | 52.2M +4.97% | 49.8M -14.15% | 58.0M -6.51% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 51.2M -2.06% | 52.2M +4.97% | 49.8M -14.15% | 58.0M -6.51% | |
Total Current Assets | 81.2M +7.92% | 75.2M -1.00% | 76.0M -1.92% | 77.5M +1.63% | |
Accumulated Depreciation | 5.1M +10.37% | 4.6M +12.92% | 4.1M +18.64% | 3.4M +19.90% | |
Property and Plant and Equipment and Net | 23.9M +41.91% | 16.8M +80.98% | 9.3M +287.06% | 2.4M +15.97% | |
Total Long-Term Assets | 239,000 +20.15% | 198,912 +9.62% | 181,449 -72.03% | 648,672 +222.20% | |
Total Assets | 108.8M +10.63% | 98.3M +6.69% | 92.2M +7.77% | 85.5M +3.18% | |
Income Taxes Payable | 1.8M +339.18% | 413,039 +16.91% | 353,282 +189.77% | 121,919 -13.11% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 10.2M +19.59% | 8.5M -47.86% | 16.3M +90.88% | 8.6M +25.37% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 4.0M +32.90% | 3.0M -32.07% | 4.4M +34.12% | 3.3M -15.39% | |
Total Liabilities | 14.2M +23.04% | 11.5M -44.51% | 20.7M +75.12% | 11.8M +10.58% | |
Retained Earnings | 64.2M +13.10% | 56.8M +31.28% | 43.3M -8.48% | 47.3M +0.57% | |
Total Stockholders Equity | 94.6M +8.98% | 86.8M +21.56% | 71.4M -3.06% | 73.7M +2.08% | |
Total Shares Outstanding | 12.8M +0.57% | 12.7M +0.39% | 12.7M N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | 24.9M -2.64% | 25.6M +90.30% | 13.5M +34.08% | 10.0M -10.80% | |
Capital Expenditures | 7.8M -3.00% | 8.0M +7.59% | 7.4M +804.05% | 823,019 +70.64% | |
Cash from Investing Activities | -8.4M -4.49% | -8.8M +10.11% | -8.0M +482.34% | -1.4M -312.11% | |
Dividends Paid | 15.0M +9.96% | 13.7M +3.44% | 13.2M +5.29% | 12.6M N/A | |
Cash from Financing Activities | -17.6M +22.78% | -14.3M +4.98% | -13.7M +7.48% | -12.7M -52,122.11% | |
Financials Ratio | |||||
Gross Margin | 76.75% -0.25% | 76.94% +0.56% | 76.50% -1.22% | 77.45% +1.04% | |
Operating Margin | 31.20% +4.03% | 29.99% -1.87% | 30.56% +4.23% | 29.32% +24.87% | |
Return on Assets | 21.71% +7.50% | 20.20% +4.35% | 19.35% +27.02% | 15.24% +25.76% | |
Return on Equity | 24.78% +1.93% | 24.31% +2.58% | 23.70% +34.72% | 17.59% +25.97% | |
Revenue Growth | 14.43% +23.22% | 11.71% -49.07% | 23.00% -16.29% | 27.48% -13.70% | |
Current Ratio | 7.98 -9.76% | 8.84 +89.89% | 4.65 -48.62% | 9.06 -18.93% | |
Cash Ratio | 5.03 -18.10% | 6.14 +101.34% | 3.05 -55.02% | 6.78 -25.43% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow